Frédéric Houssiau
13PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Mar 14, 2026
Glycomic Profiles of IgG, C3 and Alpha-1-Acid Glycoprotein (AGP) Before and One Year After Treatment for Active Lupus Nephritis.Dionysis Nikolopoulos, Ana Cindrić, Konstantinos Charitidis
|May 20, 2024
Impact of Glucocorticoid Dose on Complete Response, Serious Infections, and Mortality During the Initial Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis of the Control Arms of Randomized Controlled Trials.Gabriel Figueroa-Parra, María C Cuéllar-Gutiérrez, Mariana González-Treviño
|Oct 12, 2023
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen
|Aug 22, 2023
Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial.David Jayne, Brad Rovin, Eduardo Mysler
|Feb 11, 2022
Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?Ioannis Parodis, Farah Tamirou, Frédéric A Houssiau
|Feb 11, 2022
Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis.David Jayne, Brad Rovin, Eduardo F Mysler
Pageof 3
Frequent Collaborators
5 joint publications
Ioannis Parodis
4 joint publications
Martin Aringer
4 joint publications
Dimitrios T Boumpas
3 joint publications
Antonis Fanouriakis
3 joint publications
Richard Furie
3 joint publications
Ronald F van Vollenhoven
3 joint publications
Andrea Doria
2 joint publications
Michelle Petri
2 joint publications
Dionysis Nikolopoulos
2 joint publications
Elisabet Svenungsson
